Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis

MLA

Catherine R. Armbruster, et al. “Persistence and Evolution of Pseudomonas Aeruginosa Following Initiation of Highly Effective Modulator Therapy in Cystic Fibrosis.” MBio, vol. 15, no. 5, May 2024. EBSCOhost, https://doi.org/10.1128/mbio.00519-24.

APA

Catherine R. Armbruster, Yasmin K. Hilliam, Anna C. Zemke, Samar Atteih, Christopher W. Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R. Gaston, Stella E. Lee, Vaughn S. Cooper, & Jennifer M. Bomberger. (2024). Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis. MBio, 15(5). https://doi.org/10.1128/mbio.00519-24

Chicago

Catherine R. Armbruster, Yasmin K. Hilliam, Anna C. Zemke, Samar Atteih, Christopher W. Marshall, John Moore, Junu Koirala, et al. 2024. “Persistence and Evolution of Pseudomonas Aeruginosa Following Initiation of Highly Effective Modulator Therapy in Cystic Fibrosis.” MBio 15 (5). doi:10.1128/mbio.00519-24.